U M Saarinen-Pihkala
Overview
Explore the profile of U M Saarinen-Pihkala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
509
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vatanen A, Hou M, Huang T, Soder O, Jahnukainen T, Kurimo M, et al.
Bone Marrow Transplant
. 2017 Jan;
52(4):600-605.
PMID: 28067869
The aim of this study was to analyze the prevalence of frailty and physical health limitations among long-term survivors of high-risk neuroblastoma (HR NBL) and to investigate whether frail health...
2.
Vatanen A, Ojala T, Sarkola T, Turanlahti M, Jahnukainen T, Saarinen-Pihkala U, et al.
Bone Marrow Transplant
. 2016 Feb;
51(6):853-5.
PMID: 26828907
No abstract available.
3.
Wilhelmsson M, Vatanen A, Borgstrom B, Gustafsson B, Taskinen M, Saarinen-Pihkala U, et al.
Bone Marrow Transplant
. 2015 Mar;
50(6):850-7.
PMID: 25798676
Treatment-related late toxicities after pediatric allogeneic hematopoietic SCT (allo-HSCT) are increasingly important as long-term survival has become an expected outcome for many transplanted children and adolescents. In a retrospective cohort...
4.
Madanat-Harjuoja L, Pokhrel A, Kivivuori S, Saarinen-Pihkala U
Int J Cancer
. 2014 Mar;
135(9):2129-34.
PMID: 24623568
Population based survival studies are critical in monitoring changes in anticancer therapy, evaluating effectiveness of new treatments as well as identifying possibilities for further improvement. The previous report on cancer...
5.
Vatanen A, Wilhelmsson M, Borgstrom B, Gustafsson B, Taskinen M, Saarinen-Pihkala U, et al.
Eur J Endocrinol
. 2013 Nov;
170(2):211-8.
PMID: 24179099
Objective: The aim of the study was to evaluate long-term ovarian function after allogeneic hematopoietic stem cell transplantation (HSCT) in childhood and adolescence. Subjects And Methods: Predictive factors for ovarian...
6.
Koivusalo A, Pakarinen M, Rintala R, Saarinen-Pihkala U
Surg Today
. 2013 Apr;
44(3):517-25.
PMID: 23580079
Purpose: Neuroblastoma (NB) is treated with surgery, chemotherapy and radiotherapy. We assessed the effects of surgical resection on the outcome over a 23-year period at our institution. Methods: 85 children...
7.
Jahnukainen K, Tinkanen H, Wikstrom A, Dunkel L, Saarinen-Pihkala U, Makinen S, et al.
Leukemia
. 2012 Oct;
27(5):1183-5.
PMID: 23079961
No abstract available.
8.
Porkholm M, Bono P, Saarinen-Pihkala U, Kivivuori S
Bone Marrow Transplant
. 2012 Jun;
48(1):50-5.
PMID: 22659681
The roles of angiogenesis and angiogenic factors after allogenic hematopoietic SCT (HSCT) and during acute GVHD (aGVHD) are not known. Studies on pediatric patients are extremely scarce. Levels of angiopoietin-2...
9.
Ninomiya S, Tyybakinoja A, Borze I, Raty R, Saarinen-Pihkala U, Usvasalo A, et al.
Cytogenet Genome Res
. 2012 Mar;
136(4):246-55.
PMID: 22456238
We adopted an integrated analysis of gene copy number alterations (CNAs), copy number neutral loss of heterozygosity (CNN LOH), and microRNA (miRNA) profiling in 21 adult acute lymphoblastic leukemia (ALL)...
10.
Hovi L, Kurimo M, Taskinen M, Vettenranta J, Vettenranta K, Saarinen-Pihkala U
Bone Marrow Transplant
. 2009 Sep;
45(4):738-45.
PMID: 19718065
We present a set of tests for physical performance used for annual prospective follow-up after a pediatric transplant. Of the 103 eligible patients transplanted at a mean age of 8.8...